DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹5,674 Cr | ₹4,643 Cr | ₹4,543 Cr | ₹5,888 Cr | ₹2,811 Cr |
What is the latest Cash Flow from Operating Activities ratio of DR REDDYS LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹5,674 Cr |
| Mar2025 | ₹4,643 Cr |
| Mar2024 | ₹4,543 Cr |
| Mar2023 | ₹5,888 Cr |
| Mar2022 | ₹2,811 Cr |
How is Cash Flow from Operating Activities of DR REDDYS LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,674 Cr | 22.20 | |
| Mar2025 | ₹4,643 Cr | 2.19 | |
| Mar2024 | ₹4,543 Cr | -22.83 | |
| Mar2023 | ₹5,888 Cr | 109.46 | |
| Mar2022 | ₹2,811 Cr | - | |
Compare Cash Flow from Operating Activities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹114,937.3 Cr | 1.1% | 11.8% | 14.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹454,914.0 Cr | 3.9% | 7.8% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹300,380.0 Cr | 11.5% | 20.6% | 68% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,169.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| CIPLA | ₹114,478.0 Cr | 1.1% | 7.9% | -6.3% | Stock Analytics | |
| MANKIND PHARMA | ₹109,746.0 Cr | 5.7% | 10.8% | 15.2% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 1.1% |
11.8% |
14.9% |
| SENSEX | 5.9% |
13% |
-1.9% |
You may also like the below Video Courses